Brief: Xbrane Biopharma Positive Operating Cash Flow Is Expected To Be Achieved In Q2 2025

Xbrane Biopharma AB

28/08/2024 07:14

Aug 28 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * POSITIVE OPERATING CASH FLOW IS EXPECTED TO BE ACHIEVED IN
Q2
2025
    * IT IS ESSENTIAL THAT COMPANY CAN MAINTAIN TIMELINES OF THE
OUT
LICENSING TO ENSURE FINANCING OF THE COMPANY FROM NOV AND
ONWARDS

Source text for Eikon:  ID:nMFN2f0krX 
Further company coverage:  XBRANE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))